Reuters Market Eye - Drug makers on the BSE Sensex are likely to miss estimates when they report their December-quarter earnings, according to Thomson Reuters StarMine.
Cipla Limited , Sun Pharmaceutical Industries Limited and Dr Reddy's Laboratories Limited are likely to miss consensus forecasts, according to StarMine SmartEstimates, which places a greater emphasis on forecasts by top-rated analysts.
The drugmakers are among 11 companies on the Sensex that are yet to report October-December earnings.
Hindalco Industries Limited may post the biggest earnings disappointment, missing its consensus forecasts by 10 percent as per StarMine SmartEstimates.
The table below shows by how much in percentage terms a listed company is expected to miss wider consensus forecasts, according to StarMine SmartEstimates.
(Reporting by Abhishek Vishnoi)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app